NEUTHERAPEUTICS, LLC

Biotech · Private

Intranasal formulation of allopregnanolone (Allo), a neurosteroid molecule for Alzheimer's disease treatment

Grants
$3.0M
3 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase II · PhytoSERM for Menopausal Hot Flashes and Sustained Brain Health$1,337,363
Federal grantDepartment of Health and Human Services · Phase I · Novel Intranasal Formulations of Allopregnanolone, a Regenerative Therapeutic for Alzheimer's Disease$505,836
Federal grantDepartment of Health and Human Services · Phase II · PhytoSERM for Menopausal Hot Flashes and Sustained Brain Health$1,199,342
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1156ALLIANCE DISCOVERY, INC.——
1157PALENA THERAPEUTICS, INC.——
1158ASTRAEA THERAPEUTICS, LLC——
1159NEUTHERAPEUTICS, LLC——
1160IMAGO PHARMACEUTICALS, INC.——
1161Trove Labs Inc——
1162NANOMEDIC INC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.